Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Pietschmann

Showing results (91-100 of 210) with videos related to

Pageof 21
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2002
Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzeesJens Bukh, Thomas Pietschmann, Volker Lohmann, et al.
Microbiology Spectrum|January 17, 2024
Landscape of protein-protein interactions during hepatitis C virus assembly and releaseAlina Matthaei, Sebastian Joecks, Annika Frauenstein, et al.
Microbiology Spectrum|June 21, 2023
Mouse Liver-Expressed Shiftless Is an Evolutionarily Conserved Antiviral Effector Restricting Human and Murine HepacivirusesYudi Zhang, Volker Kinast, Julie Sheldon, et al.
Journal of Virology|November 27, 2004
Prototype foamy virus envelope glycoprotein leader peptide processing is mediated by a furin-like cellular protease, but cleavage is not essential for viral infectivityAnja Duda, Annett Stange, Daniel Lüftenegger, et al.
Antiviral Research|April 27, 2010
Development of novel therapies for hepatitis CStanley M Lemon, Jane A McKeating, Thomas Pietschmann, et al.
Journal of Virology|October 4, 2013
Characterization of hepatitis C virus intra- and intergenotypic chimeras reveals a role of the glycoproteins in virus envelopmentEike Steinmann, Juliane Doerrbecker, Martina Friesland, et al.
Hepatology (Baltimore, Md.)|October 13, 2009
Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin ASandra Ciesek, Eike Steinmann, Heiner Wedemeyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 3, 2006
Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimerasThomas Pietschmann, Artur Kaul, George Koutsoudakis, et al.
Antimicrobial Agents and Chemotherapy|June 10, 2020
Filovirus Antiviral Activity of Cationic Amphiphilic Drugs Is Associated with Lipophilicity and Ability To Induce PhospholipidosisAntonia P Gunesch, Francisco J Zapatero-Belinchón, Lukas Pinkert, et al.
The EMBO Journal|October 31, 2013
Interferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronavirusesOle J Hamming, Ewa Terczyńska-Dyla, Gabrielle Vieyres, et al.
Pageof 21

Showing results (91-100 of 210) with videos related to

Sort By:
Pageof 21
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2002
Mutations that permit efficient replication of hepatitis C virus RNA in Huh-7 cells prevent productive replication in chimpanzeesJens Bukh, Thomas Pietschmann, Volker Lohmann, et al.
Microbiology Spectrum|January 17, 2024
Landscape of protein-protein interactions during hepatitis C virus assembly and releaseAlina Matthaei, Sebastian Joecks, Annika Frauenstein, et al.
Microbiology Spectrum|June 21, 2023
Mouse Liver-Expressed Shiftless Is an Evolutionarily Conserved Antiviral Effector Restricting Human and Murine HepacivirusesYudi Zhang, Volker Kinast, Julie Sheldon, et al.
Journal of Virology|November 27, 2004
Prototype foamy virus envelope glycoprotein leader peptide processing is mediated by a furin-like cellular protease, but cleavage is not essential for viral infectivityAnja Duda, Annett Stange, Daniel Lüftenegger, et al.
Antiviral Research|April 27, 2010
Development of novel therapies for hepatitis CStanley M Lemon, Jane A McKeating, Thomas Pietschmann, et al.
Journal of Virology|October 4, 2013
Characterization of hepatitis C virus intra- and intergenotypic chimeras reveals a role of the glycoproteins in virus envelopmentEike Steinmann, Juliane Doerrbecker, Martina Friesland, et al.
Hepatology (Baltimore, Md.)|October 13, 2009
Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin ASandra Ciesek, Eike Steinmann, Heiner Wedemeyer, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 3, 2006
Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimerasThomas Pietschmann, Artur Kaul, George Koutsoudakis, et al.
Antimicrobial Agents and Chemotherapy|June 10, 2020
Filovirus Antiviral Activity of Cationic Amphiphilic Drugs Is Associated with Lipophilicity and Ability To Induce PhospholipidosisAntonia P Gunesch, Francisco J Zapatero-Belinchón, Lukas Pinkert, et al.
The EMBO Journal|October 31, 2013
Interferon lambda 4 signals via the IFNλ receptor to regulate antiviral activity against HCV and coronavirusesOle J Hamming, Ewa Terczyńska-Dyla, Gabrielle Vieyres, et al.
Pageof 21